ACC 2023 Conference Coverage
Playback speed
10 seconds
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
By
ACC 2023 Conference Coverage
FEATURING
Barry Borlaug
By
ACC 2023 Conference Coverage
FEATURING
Barry Borlaug
1,320 views
March 15, 2023
Comments 3
Login to view comments.
Click here to Login
Videos